Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 61, Issue 10, Pages 1849-1856
Publisher
Springer Nature
Online
2012-03-28
DOI
10.1007/s00262-012-1231-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
- (2011) Fangfang Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
- (2011) Sylvain Ladoire et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
- (2011) Marie Tosolini et al. CANCER RESEARCH
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
- (2011) Sylvain Ladoire et al. JOURNAL OF PATHOLOGY
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
- (2011) Naganari Ohkura et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
- (2011) Hans Bösmüller et al. VIRCHOWS ARCHIV
- The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
- (2010) E. M. de Kruijf et al. CLINICAL CANCER RESEARCH
- T regulatory cells in cancer: recent advances and therapeutic potential
- (2010) Eyad Elkord et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
- (2010) Katsuhiko Shimizu et al. Journal of Thoracic Oncology
- Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
- (2009) Hiroyuki Suzuki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy
- (2008) Hidenari Nagai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer treatment: the combination of vaccination with other therapies
- (2008) Mads Hald Andersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer
- (2008) Hui Liu et al. CANCER SCIENCE
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer
- (2008) K. I. Al-Shibli et al. CLINICAL CANCER RESEARCH
- Tumor-specific regulatory T cells in cancer patients
- (2008) Sytse J. Piersma et al. HUMAN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More